20+8 Interpret

Recently, the "Shenzhen Municipal People's Government's Opinions on the Development and Greeting Strategic Emerging Industry Cluster and Cultivating Future Industry" (hereinafter referred to as "Opinions") was officially released. The introduction of "Opinions" has strengthened confidence in the development of related strategic emerging industries and future industries. Shenzhen Biomedical Representative Enterprise said that the agglomeration effect of the industry will help Shenzhen build a highland of technology and industrial innovation with global influence and enhance global competitiveness.

"Real policies for actual difficulties"

"Opinions clearly include the" high -end medical device industry cluster "in the key areas of strategic emerging industries, and propose to develop new medical images, life monitoring and life support areas. The perfect guarantee measures are a great excitement for Mai Rui. "Mindray Medical Relevant person in charge said.

Not long ago, the Longhua Science and Technology Industrial Park was officially launched. Under the Dongfeng of the cultivation of high -end medical device industry clusters in Shenzhen, Mai Ruilonghua Science and Technology Industrial Park has created a high -end manufacturing benchmark with hard nuclear innovation, deepening industrial cooperation with a integrated development attitude, and helping the high -quality development of Shenzhen's medical device industry.

In Mai Rui's view, Shenzhen, as the national medical device industry, is a leading town in the national medical device industry, whether it is innovative basic strength, industrial concentration, export amount, and listed enterprise volume. The government meets the actual situation when formulating policies and related planning, understanding the pain points of the industry, and making real and accurate policies for actual difficulties, which has greatly promoted the development of the industry.

As a backbone member of the National High -performance Medical Device Manufacturing Innovation Center, Mai Rui will also cooperate closely with domestic advanced enterprises and research institutions to jointly carry out technical tackling. In the next step, Mai Rui will strengthen the in -depth research on parameters of the intensive illness and attack the ultrasound image technology.

Policies Focus on strengthening confidence in high -quality development of enterprises

The "Opinions" states that it is necessary to focus on the development of precision medical care, rehabilitation pension, modern agricultural products, medical cosmetics, cosmetics and other industries, expand high -quality supply of health products, strengthen recycled medical materials, rehabilitation appliances, germplasm resources and genetic excavations, precision drugs Development and other technologies, build innovative platforms such as precise nutrition research and development and application platforms, and health equipment measurement testing platforms.

Huada, which deeply cultivates genetic technology, has been applied to the cutting -edge multi -sets of academic achievements in medical health, resource preservation and other fields for more than 20 years since its establishment. At the same time, it has provided autonomous controllable and controllable actual needs of national people's livelihood and people's livelihood for precision medical care and precision health. Advanced equipment, technical guarantee and solutions.

Taking the core tool technology as an example, Huada independently developed the STEREO-SEQ technology of time and space. It is another milestone progress in life science tools since the invention of microscope and sequencing technology, which is expected to bring the third scientific and technological revolution in the field of life science. "In the future, with the further enlargement of the gathering effect, Shenzhen will definitely produce more iconic results of global scientific and technological innovation in the field of life sciences, and it will be promising in the life and health industry." The relevant person in charge of Huada said.

In terms of synthetic creatures, the Opinions clearly use it as one of the key development directions of the future industry, and focus on the development of synthetic biological underlying technology, quantitative synthetic biotechnology, biological creation and other fields. As a local vaccine company in Guangdong Province, Kangtai Biological has many years of exploration and practical experience in synthetic biotechnology. The introduction of this policy has firm confidence for the high -quality and sustainable development of enterprises.

"Under the guidance of" Opinions ", we will be based on the existing reorganized VLP hepatitis B vaccine, adenovirus vector new crown vaccine and other synthetic biological technologies to increase the technical layout of artificial synthetic VLP vaccine carriers, virus carrier vaccines, etc. Adventory adenovirus, VSV virus, hepatitis B virus particles, pharmaceutical virus particles, etc. are made into delivery carriers, and the target antigen is loaded through physical chemistry and other methods to make new types of reorganized sub -vaccines such as vaccine to achieve greater breakthroughs. " Relevant person in charge said.

Frontier areas such as biopharmaceuticals and gene therapy will form regional agglomeration

"Twenty industrial clusters are the subdivisions of Shenzhen's past seven strategic emerging industries. There are information industry sectors, biomedical sectors, marine sectors, digital economy sectors, etc. From the perspective of industrial development, I think the" Opinions " The introduction will help Shenzhen to make global influence in the field of biomedicine. "Said Zhao Shumei, deputy general manager of micro -biological biology.

Recently, the state has introduced the "14th Five-Year Plan" biological economic development plan to increase policy support. In the next 5-10 years, the biomedical industry is expected to usher in rapid development. At the same time, the Drug Review and Inspection of the State Drug Administration is settled in Shenzhen, which is conducive to accelerating the registration and listing of innovative drugs and biotechnology products, and creating a better policy environment for the development of the biomedical industry.

The "Opinions" states that supporting Pingshan, Nanshan, Futian, Longgang, Guangming, and Dapeng to create industrial clusters, and promoting the biomedical industry cluster to become a new highlight of industrial development.Among them, Pingshan District is positioned as the core gathering area, which will promote the formation of advanced areas such as biological innovation drugs, high -end preparations, vaccines, cell therapy and gene therapy."Our wholly -owned subsidiary Shenzhen Micro Capital Pharmaceutical was introduced to Pingshan biomedical enterprises in the pilot project of the Shenzhen National Biomedical Base Biopharmaceutical Enterprise Accelerator in 2009. It is also the first original innovation medicine 'Sidamonamine' production in my country. Base. With the development of the company, the second phase of Shenzhen Micro Capital Pharmaceutical is under planning. The guarantee of the new policy on the industrial space has given the enterprise a lot of confidence. "Zhao Shumei said.Content source: South +

Reporter: Zhang Xiujuan

- END -